| Literature DB >> 27446961 |
Alison O Booth1, Carole Lowis2, Steven J Hunter3, Moira Dean4, Chris R Cardwell5, Michelle C McKinley5.
Abstract
Aim. The purpose of this study was to develop and evaluate a computer-based, dietary, and physical activity self-management program for people recently diagnosed with type 2 diabetes. Methods. The computer-based program was developed in conjunction with the target group and evaluated in a 12-week randomised controlled trial (RCT). Participants were randomised to the intervention (computer-program) or control group (usual care). Primary outcomes were diabetes knowledge and goal setting (ADKnowl questionnaire, Diabetes Obstacles Questionnaire (DOQ)) measured at baseline and week 12. User feedback on the program was obtained via a questionnaire and focus groups. Results. Seventy participants completed the 12-week RCT (32 intervention, 38 control, mean age 59 (SD) years). After completion there was a significant between-group difference in the "knowledge and beliefs scale" of the DOQ. Two-thirds of the intervention group rated the program as either good or very good, 92% would recommend the program to others, and 96% agreed that the information within the program was clear and easy to understand. Conclusions. The computer-program resulted in a small but statistically significant improvement in diet-related knowledge and user satisfaction was high. With some further development, this computer-based educational tool may be a useful adjunct to diabetes self-management. This trial is registered with clinicaltrials.gov NCT number NCT00877851.Entities:
Mesh:
Year: 2016 PMID: 27446961 PMCID: PMC4944056 DOI: 10.1155/2016/3192673
Source DB: PubMed Journal: J Diabetes Res Impact factor: 4.011
Figure 1Development of the LWD program.
Figure 2Flow of participants through the RCT.
Baseline characteristics of participants randomly assigned to intervention and control group.
| Control | Intervention | |
|---|---|---|
| Age (years) (mean (SD)) | 60 (10.7) | 58 (9.1) |
| Female gender, % ( | 37 (16) | 46 (19) |
| Married or living with partner, % ( | 79 (34) | 76 (31) |
| Employment status, % ( | — | — |
| Employed full time | 33 (14) | 32 (13) |
| Employed part time | 14 (6) | 12 (5) |
| Retired | 40 (17) | 34 (14) |
| Education % ( | — | — |
| Secondary level | 33 (14) | 49 (20) |
| College | 16 (7) | 7 (3) |
| University | 44 (19) | 39 (16) |
| Ever been to a group education session, yes (%) | 26 (11) | 51 (21) |
| Visited a dietitian since diagnosis, yes (%) | 65 (28) | 73 (30) |
| Taking medication for diabetes, yes (%) | 42 (18) | 49 (20) |
| Taking insulin for diabetes, yes (%) | 9 (4) | 5 (2) |
| Weight (Kg) (mean (SD)) | 90.4 (15.1) | 91.6 (15.3) |
| BMI (Kg/m2) (mean (SD)) | 31.7 (4.9) | 32.0 (5.4) |
| Waist circumference (cm) (mean (SD)) | 109.8 (11.5) | 110.1 (10.7) |
| Hip circumference (cm) (mean (SD)) | 115.6 (10.2) | 115.0 (11.2) |
| Waist to hip ratio ((waist cm)/hip (cm)) (mean (SD)) | 0.95 (0.07) | 0.96 (0.06) |
| Systolic blood pressure (mmHg) (mean (SD)) | 136 (15.0) | 136 (16.0) |
| Diastolic blood pressure (mmHg) (mean (SD)) | 82 (9.0) | 86 (8.9) |
Primary and secondary outcomes: pre- and postintervention questionnaire data according to randomisation.
| Control | Intervention | Mean difference (CI) |
| |||
|---|---|---|---|---|---|---|
| Baseline | Week 12 | Baseline | Week 12 | |||
|
| ||||||
| ADKnowl: overall scorea | 60 (14.3) | 64 (14.2) | 62 (13.8) | 67 (10.4) | 1.7 (−1.7, 5.1) | 0.37 |
| ADKnowl: diet and food (item-set 10, 11, 12)a | 59 (16.0) | 60 (18.4) | 62 (17.4) | 67 (15.8) | 5.1 (−0.9, 11.1) | 0.09 |
| ADKnowl: effects of physical activity (item-set 8, 9)a | 40 (26.7) | 42 (27.3) | 41 (26.2) | 47 (24.5) | 5.2 (−2.9, 13.4) | 0.31 |
| ADKnowl: reducing the risk of complications (item-set 1, 15, 16, 17)a | 88 (13.1) | 89 (12.6) | 89 (12.2) | 89 (10.4) | −0.7 (−5, 3.6) | 0.76 |
| DES5: setting and achieving goals (items 5–14)a | 3.8 (0.5) | 3.8 (0.6) | 3.6 (0.8) | 3.8 (0.5) | 0 (−.29, .29) | 0.99 |
|
| ||||||
|
| ||||||
| Diabetes obstacles questionnaire (knowledge and beliefs scale)b | 3.4 (0.5) | 3.3 (0.6) | 3.1 (0.6) | 3.5 (1.0) | 0.4 (0.1, 0.7) |
|
| ADDQoL: average weighted impact scorec | −0.9 (1.0) | −0.6 (0.8) | −1.2 (1.3) | −1.0 (1.3) | −0.3 (−0.7, 0.2) | 0.28 |
| PHQ-9: overall scored | 6.2 (5.9) | 5.3 (4.7) | 8.3 (7.9) | 8.0 (8.1) | 3.4 (−0.2, 6.7) | 0.15 |
| SF36 health survey: overall score | 60 (23.8) | 69 (18.0) | 63 (27.9) | 63 (30.4) | −4.8 (−10.4, 0.7) | 0.09 |
| SF36 health survey: mental health | 69 (20.5) | 70 (17.0) | 65 (24.1) | 61 (28.7) | −4.7 (−10.8, 1.4) | 0.90 |
| SF36 health survey: physical health | 55 (25.2) | 61 (18.4) | 61 (26.8) | 60 (29.5) | −3.9 (−9.0, 1.0) | 0.12 |
| SF36 health survey subscale: physical function | 62 (31.1) | 68 (26.9) | 73 (29.7) | 73 (31.9) | −0.6 (−7.7, 6.4) | 0.86 |
| SF36 health survey subscale: role limitations due to physical health | 54 (44.4) | 72 (38.6) | 66 (44.2) | 61 (47.1) | −14.9 (−29.3, −0.6) |
|
| SF36 health survey subscale: general health | 53 (23.4) | 58 (18.1) | 55 (26.3) | 55 (27) | −1.7 (−8.3, 4.8) | 0.59 |
| SF36 health survey subscale: vitality | 48 (22.9) | 52 (21.1) | 51 (24.5) | 51 (24.6) | −1.6 (−8.5, 5.3) | 0.65 |
| SF36 health survey subscale: social functioning | 73 (28) | 87 (20.1) | 74 (31.7) | 73 (34.7) | −12.2 (−20.8, −3.6) |
|
| SF36 health survey subscale: role limitations due to mental health | 64 (41.8) | 81 (36.5) | 60 (46.7) | 62 (48.2) | −11.7 (−28.5, 5.1) | 0.17 |
aPercent of items correct (SD).
bDiabetes Empowerment Scale, scored from 1 to 5; a lower score indicates greater goal setting ability/confidence.
cScored from −9 (maximum negative impact) to +9 (maximum positive impact).
dPatient Health Questionnaire (depression) score; a higher score indicates higher severity of depression.
∧ P value, between-group comparison at week 12, adjusted for baseline (ANCOVA).
Within group change, P < 0.05 (paired samples t-test).
Secondary outcomes: anthropometric and blood parameters before and after intervention1 according to randomisation.
| Control | Intervention |
| |||
|---|---|---|---|---|---|
| Week 0 | Week 12 | Week 0 | Week 12 | ||
| Weight (Kg) | 89.4 (14.9) | 89.4 (14.7) | 89.4 (13.7) | 89.8 (13.8) | 0.47 |
| BMI (Kg/m2) | 31.3 (4.6) | 31.3 (4.5) | 31.3 (5.1) | 31.4 (5.0) | 0.81 |
| Waist circumference (cm) | 109.0 (11.7) | 108.5 (11.6) | 108.4 (10.1) | 107.5 (9.8) | 0.56 |
| Hip circumference (cm) | 114.9 (8.9) | 114.3 (8.8) | 114.2 (10.5) | 114.4 (11.2) | 0.47 |
| Waist: hip | 0.95 (0.07) | 0.95 (0.07) | 0.95 (0.06) | 0.92 (0.16) | 0.16 |
| Systolic blood pressure (mm/Hg) | 137 (15.2) | 137 (15.1) | 137 (14.9) | 138 (14.2) | 0.89 |
| Diastolic blood pressure (mm/Hg) | 82 (8.5) | 83 (8.6) | 85 (7.4) | 85 (9.2) | 0.83 |
| Total cholesterol (mmol/L) | 4.3 (1.2) | 4.2 (1.0) | 4.4 (1.07) | 4.3 (0.96) | 0.52 |
| HDL cholesterol (mmol/L) | 1.2 (0.27) | 1.2 (0.33) | 1.2 (0.32) | 1.2 (0.30) | 0.75 |
| Calculated LDL cholesterol (mmol/L) | 2.3 (0.97) | 2.1 (0.91) | 2.4 (0.93) | 2.2 (0.77) | 0.66 |
| Triglycerides (mmol/L) | 1.9 (0.70) | 1.9 (1.04) | 1.7 (0.75) | 1.9 (0.94) | 0.36 |
| HbA1c (DCCT%) | 6.4 (1.1) | 6.5 (1.1) | 6.4 (0.9) | 6.4 (0.8) | 0.94 |
| Fasting glucose (mmol/L) | 8.2 (2.5) | 8.1 (2.3) | 7.7 (1.8) | 8.3 (1.9) | 0.12 |
| Insulin (mU/L) | 12.8 (7.9) | 16.2 (14.9) | 15.4 (13.8) | 19.8 (25.1) | 0.43 |
1Data given as mean (standard deviation).
Between groups at week 12 after controlling for baseline (one-way ANCOVA).
Pre- and postintervention nutrient intake according to randomisation1.
| Control | Intervention | Mean difference (CI) |
| |||
|---|---|---|---|---|---|---|
| Baseline | Week 12 | Baseline | Week 12 | |||
| Energy (Kcal) | 1626.8 (494.0) | 1697.2 (592.6) | 1858.5 (453.6) | 1804.7 (429.4) | 28.8 (−257, 314) | 0.841 |
| Fat (% total energy) | 33.3 (4.8) | 30.6 (5.8) | 31.6 (7.1) | 33.0 (6.9) | 2.1 (−1.0, 5.3) | 0.182 |
| Protein (% energy) | 19.0 (3.5) | 18.6 (3.0) | 17.5 (2.8) | 18.6 (3.6) | 0.5 (−1.2, 2.2) | 0.542 |
| Carbohydrate (% energy) | 43.5 (6.8) | 47.4 (7.0) | 45.3 (6.1) | 43.2 (7.6) | −3.5 (−7.2, 0.1) | 0.058 |
| Sugars (g) | 65.9 (25.7) | 75.2 (29.5) | 85.1 (31.4) | 80.2 (43.6) | 9.1 (−14.9, 21.7) | 0.712 |
| Sodium (mg) | 2548.8 (897.3) | 2710.4 (1263.1) | 2771.1 (851.1) | 2587.1 (868.3) | −259 (−853, 334) | 0.384 |
| Fibre (g) | 13.7 (5.2) | 15.9 (7.3) | 13.4 (16.1) | 14.8 (4.9) | −1.7 (−4.9, 1.5) | 0.285 |
1Data given as mean (standard deviation).
Between groups at week 12 after controlling for baseline (one-way ANCOVA).